Home > Insider Trading > Filing (0001393825-20-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1321834	Akers Biosciences Inc.	AKER	In Vitro & In Vivo Diagnostic Substances (2835)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1393825	Hudson Bay Capital Management Lp	777 Third Ave., 30Th Floor New York NY 10017		No	No	Yes	No
1416593	Sander Gerber	C/O Hudson Bay Capital Management, L.p. 777 Third Avenue, 30Th Floor New York NY 10017		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value ("Common Stock")	Acquisiton	2019-12-09	19,353	$2.96	104,018	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-09	50,000	$2.99	154,018	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-10	30,000	$2.97	184,018	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-11	26,406	$3.10	210,424	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-11	6,019	$3.05	216,443	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-12	20,600	$2.98	237,043	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-13	6,000	$3.02	243,043	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-16	5,000	$3.07	248,043	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-17	3,000	$3.03	251,043	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-18	7,500	$3.07	258,043	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-19	2,700	$3.08	261,243	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-20	8,000	$3.02	269,243	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The securities are held by Hudson Bay Master Fund, Ltd. (the "Fund"). Hudson Bay Capital Management LP (the "Investment Manager") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein.